- Home
- EUDA vs TARA Comparison
EUDA vs TARA Comparison
Compare EUDA & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EUDA
- TARA
- Stock Information
- Founded
- EUDA 2021
- TARA N/A
- Country
- EUDA Singapore
- TARA United States
- Employees
- EUDA N/A
- TARA N/A
- Industry
- EUDA Blank Checks
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EUDA Finance
- TARA Health Care
- Exchange
- EUDA Nasdaq
- TARA Nasdaq
- Market Cap
- EUDA 139.3M
- TARA 136.3M
- IPO Year
- EUDA N/A
- TARA N/A
- Fundamental
- Price
- EUDA $3.85
- TARA $4.01
- Analyst Decision
- EUDA
- TARA Strong Buy
- Analyst Count
- EUDA 0
- TARA 4
- Target Price
- EUDA N/A
- TARA $22.67
- AVG Volume (30 Days)
- EUDA 105.7K
- TARA 226.8K
- Earning Date
- EUDA 01-01-0001
- TARA 03-05-2025
- Dividend Yield
- EUDA N/A
- TARA N/A
- EPS Growth
- EUDA N/A
- TARA N/A
- EPS
- EUDA N/A
- TARA N/A
- Revenue
- EUDA $3,811,496.00
- TARA N/A
- Revenue This Year
- EUDA $66.63
- TARA N/A
- Revenue Next Year
- EUDA $119.95
- TARA N/A
- P/E Ratio
- EUDA N/A
- TARA N/A
- Revenue Growth
- EUDA N/A
- TARA N/A
- 52 Week Low
- EUDA $1.64
- TARA $1.60
- 52 Week High
- EUDA $6.30
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- EUDA 45.38
- TARA 48.81
- Support Level
- EUDA $3.59
- TARA $3.90
- Resistance Level
- EUDA $4.04
- TARA $4.53
- Average True Range (ATR)
- EUDA 0.20
- TARA 0.30
- MACD
- EUDA -0.02
- TARA -0.03
- Stochastic Oscillator
- EUDA 20.31
- TARA 38.04
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).